Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Immunobiology|July 1, 1986
Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-IIIL Fontana, M C Sirianni, G de Sanctis, et al.
Blood|January 1, 1988
Establishment of a new Epstein-Barr virus-immortalized cell line from chronic lymphocytic leukemia with trisomy of chromosome 12 that produces monoclonal IgM against a sheep RBC antigenM Crescenzi, M Napolitano, M Carbonari, et al.
Schizophrenia Bulletin|January 1, 1982
Attentional and perceptual disturbances in children with Tourette's syndrome, attention deficit disorder, and epilepsyD F Harcherik, C M Carbonari, S E Shaywitz, et al.
Clinical Allergy|November 1, 1986
IgG anti-IgE in circulating immune complexes in the hyper-IgE syndromeR Paganelli, I Quinti, M Carbonari, et al.
The New England Journal of Medicine|January 11, 1990
Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasiaM Carbonari, M Cherchi, R Paganelli, et al.
Schizophrenia Bulletin|January 1, 1982
The epidemiology of Tourette's syndrome: a pilot studyJ Jagger, B A Prusoff, D J Cohen, et al.
Clinical Immunology and Immunopathology|November 1, 1996
Comparison of the Vbeta repertoire in peripheral blood and in lymph nodes of HIV-infected subjects reveals skewed usage predominantly in CD8+ T cellsM Carbonari, M Cibati, A M Pesce, et al.
Blood|March 1, 1994
Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric methodM Carbonari, M Cibati, M Cherchi, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1988
Complement activation is variably affected by fibronectin preparations obtained through different proceduresA Fattorossi, S Le Moli, O Pontesilli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cellsL Frasca, P Del Porto, L Tuosto, et al.
Pageof 8